Global Companion Diagnostics (CDx) Development Services Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 24 Feb 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Companion Diagnostics (CDx) Development Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Companion Diagnostics (CDx) Development Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Companion Diagnostics (CDx) Development Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Companion Diagnostics (CDx) Development Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Companion Diagnostics (CDx) Development Services total market, 2018-2029, (USD Million)
Global Companion Diagnostics (CDx) Development Services total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Companion Diagnostics (CDx) Development Services total market, key domestic companies and share, (USD Million)
Global Companion Diagnostics (CDx) Development Services revenue by player and market share 2018-2023, (USD Million)
Global Companion Diagnostics (CDx) Development Services total market by Type, CAGR, 2018-2029, (USD Million)
Global Companion Diagnostics (CDx) Development Services total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Companion Diagnostics (CDx) Development Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q² Solutions, ResearchDx, Almac Diagnostic Services, Biocartis and Cerba Research, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Companion Diagnostics (CDx) Development Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Companion Diagnostics (CDx) Development Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Companion Diagnostics (CDx) Development Services Market, Segmentation by Type
    Feasibility Studies
    Assay Development
    Analytical Validation
    Clinical Validation
    Others

Global Companion Diagnostics (CDx) Development Services Market, Segmentation by Application
    Infectious Diseases
    Neurological Disorders

Companies Profiled:
    Geneuity-Clinical Research Services
    Interpace Biosciences
    Labcorp
    Quest Diagnostics
    Q² Solutions
    ResearchDx
    Almac Diagnostic Services
    Biocartis
    Cerba Research
    Eurofins Scientific
    MLM Medical Labs
    Qiagen
    BGI Genomics
    MEDx Translational Medicine
    Medical Biological Laboratories (MBL)
    Novogene

Key Questions Answered
1. How big is the global Companion Diagnostics (CDx) Development Services market?
2. What is the demand of the global Companion Diagnostics (CDx) Development Services market?
3. What is the year over year growth of the global Companion Diagnostics (CDx) Development Services market?
4. What is the total value of the global Companion Diagnostics (CDx) Development Services market?
5. Who are the major players in the global Companion Diagnostics (CDx) Development Services market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Companion Diagnostics (CDx) Development Services Introduction
    1.2 World Companion Diagnostics (CDx) Development Services Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Companion Diagnostics (CDx) Development Services Total Market by Region (by Headquarter Location)
        1.3.1 World Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
        1.3.3 China Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
        1.3.4 Europe Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
        1.3.5 Japan Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
        1.3.6 South Korea Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
        1.3.7 ASEAN Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
        1.3.8 India Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Companion Diagnostics (CDx) Development Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Companion Diagnostics (CDx) Development Services Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.2 World Companion Diagnostics (CDx) Development Services Consumption Value by Region
        2.2.1 World Companion Diagnostics (CDx) Development Services Consumption Value by Region (2018-2023)
        2.2.2 World Companion Diagnostics (CDx) Development Services Consumption Value Forecast by Region (2024-2029)
    2.3 United States Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.4 China Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.5 Europe Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.6 Japan Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.7 South Korea Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.8 ASEAN Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)
    2.9 India Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029)

3 World Companion Diagnostics (CDx) Development Services Companies Competitive Analysis
    3.1 World Companion Diagnostics (CDx) Development Services Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Companion Diagnostics (CDx) Development Services Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Companion Diagnostics (CDx) Development Services in 2022
        3.2.3 Global Concentration Ratios (CR8) for Companion Diagnostics (CDx) Development Services in 2022
    3.3 Companion Diagnostics (CDx) Development Services Company Evaluation Quadrant
    3.4 Companion Diagnostics (CDx) Development Services Market: Overall Company Footprint Analysis
        3.4.1 Companion Diagnostics (CDx) Development Services Market: Region Footprint
        3.4.2 Companion Diagnostics (CDx) Development Services Market: Company Product Type Footprint
        3.4.3 Companion Diagnostics (CDx) Development Services Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Companion Diagnostics (CDx) Development Services Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Companion Diagnostics (CDx) Development Services Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Companion Diagnostics (CDx) Development Services Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Companion Diagnostics (CDx) Development Services Consumption Value Comparison
        4.2.1 United States VS China: Companion Diagnostics (CDx) Development Services Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Companion Diagnostics (CDx) Development Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Companion Diagnostics (CDx) Development Services Companies and Market Share, 2018-2023
        4.3.1 United States Based Companion Diagnostics (CDx) Development Services Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Companion Diagnostics (CDx) Development Services Revenue, (2018-2023)
    4.4 China Based Companies Companion Diagnostics (CDx) Development Services Revenue and Market Share, 2018-2023
        4.4.1 China Based Companion Diagnostics (CDx) Development Services Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Companion Diagnostics (CDx) Development Services Revenue, (2018-2023)
    4.5 Rest of World Based Companion Diagnostics (CDx) Development Services Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Companion Diagnostics (CDx) Development Services Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Companion Diagnostics (CDx) Development Services Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Companion Diagnostics (CDx) Development Services Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Feasibility Studies
        5.2.2 Assay Development
        5.2.3 Analytical Validation
        5.2.4 Clinical Validation
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023)
        5.3.2 World Companion Diagnostics (CDx) Development Services Market Size by Type (2024-2029)
        5.3.3 World Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Companion Diagnostics (CDx) Development Services Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Infectious Diseases
        6.2.2 Neurological Disorders
    6.3 Market Segment by Application
        6.3.1 World Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023)
        6.3.2 World Companion Diagnostics (CDx) Development Services Market Size by Application (2024-2029)
        6.3.3 World Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Geneuity-Clinical Research Services
        7.1.1 Geneuity-Clinical Research Services Details
        7.1.2 Geneuity-Clinical Research Services Major Business
        7.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product and Services
        7.1.4 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Geneuity-Clinical Research Services Recent Developments/Updates
        7.1.6 Geneuity-Clinical Research Services Competitive Strengths & Weaknesses
    7.2 Interpace Biosciences
        7.2.1 Interpace Biosciences Details
        7.2.2 Interpace Biosciences Major Business
        7.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Product and Services
        7.2.4 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Interpace Biosciences Recent Developments/Updates
        7.2.6 Interpace Biosciences Competitive Strengths & Weaknesses
    7.3 Labcorp
        7.3.1 Labcorp Details
        7.3.2 Labcorp Major Business
        7.3.3 Labcorp Companion Diagnostics (CDx) Development Services Product and Services
        7.3.4 Labcorp Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Labcorp Recent Developments/Updates
        7.3.6 Labcorp Competitive Strengths & Weaknesses
    7.4 Quest Diagnostics
        7.4.1 Quest Diagnostics Details
        7.4.2 Quest Diagnostics Major Business
        7.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Product and Services
        7.4.4 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Quest Diagnostics Recent Developments/Updates
        7.4.6 Quest Diagnostics Competitive Strengths & Weaknesses
    7.5 Q² Solutions
        7.5.1 Q² Solutions Details
        7.5.2 Q² Solutions Major Business
        7.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Product and Services
        7.5.4 Q² Solutions Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Q² Solutions Recent Developments/Updates
        7.5.6 Q² Solutions Competitive Strengths & Weaknesses
    7.6 ResearchDx
        7.6.1 ResearchDx Details
        7.6.2 ResearchDx Major Business
        7.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Product and Services
        7.6.4 ResearchDx Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 ResearchDx Recent Developments/Updates
        7.6.6 ResearchDx Competitive Strengths & Weaknesses
    7.7 Almac Diagnostic Services
        7.7.1 Almac Diagnostic Services Details
        7.7.2 Almac Diagnostic Services Major Business
        7.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product and Services
        7.7.4 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Almac Diagnostic Services Recent Developments/Updates
        7.7.6 Almac Diagnostic Services Competitive Strengths & Weaknesses
    7.8 Biocartis
        7.8.1 Biocartis Details
        7.8.2 Biocartis Major Business
        7.8.3 Biocartis Companion Diagnostics (CDx) Development Services Product and Services
        7.8.4 Biocartis Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Biocartis Recent Developments/Updates
        7.8.6 Biocartis Competitive Strengths & Weaknesses
    7.9 Cerba Research
        7.9.1 Cerba Research Details
        7.9.2 Cerba Research Major Business
        7.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Product and Services
        7.9.4 Cerba Research Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Cerba Research Recent Developments/Updates
        7.9.6 Cerba Research Competitive Strengths & Weaknesses
    7.10 Eurofins Scientific
        7.10.1 Eurofins Scientific Details
        7.10.2 Eurofins Scientific Major Business
        7.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Product and Services
        7.10.4 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Eurofins Scientific Recent Developments/Updates
        7.10.6 Eurofins Scientific Competitive Strengths & Weaknesses
    7.11 MLM Medical Labs
        7.11.1 MLM Medical Labs Details
        7.11.2 MLM Medical Labs Major Business
        7.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Product and Services
        7.11.4 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 MLM Medical Labs Recent Developments/Updates
        7.11.6 MLM Medical Labs Competitive Strengths & Weaknesses
    7.12 Qiagen
        7.12.1 Qiagen Details
        7.12.2 Qiagen Major Business
        7.12.3 Qiagen Companion Diagnostics (CDx) Development Services Product and Services
        7.12.4 Qiagen Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Qiagen Recent Developments/Updates
        7.12.6 Qiagen Competitive Strengths & Weaknesses
    7.13 BGI Genomics
        7.13.1 BGI Genomics Details
        7.13.2 BGI Genomics Major Business
        7.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Product and Services
        7.13.4 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 BGI Genomics Recent Developments/Updates
        7.13.6 BGI Genomics Competitive Strengths & Weaknesses
    7.14 MEDx Translational Medicine
        7.14.1 MEDx Translational Medicine Details
        7.14.2 MEDx Translational Medicine Major Business
        7.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product and Services
        7.14.4 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 MEDx Translational Medicine Recent Developments/Updates
        7.14.6 MEDx Translational Medicine Competitive Strengths & Weaknesses
    7.15 Medical Biological Laboratories (MBL)
        7.15.1 Medical Biological Laboratories (MBL) Details
        7.15.2 Medical Biological Laboratories (MBL) Major Business
        7.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product and Services
        7.15.4 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Medical Biological Laboratories (MBL) Recent Developments/Updates
        7.15.6 Medical Biological Laboratories (MBL) Competitive Strengths & Weaknesses
    7.16 Novogene
        7.16.1 Novogene Details
        7.16.2 Novogene Major Business
        7.16.3 Novogene Companion Diagnostics (CDx) Development Services Product and Services
        7.16.4 Novogene Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Novogene Recent Developments/Updates
        7.16.6 Novogene Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Companion Diagnostics (CDx) Development Services Industry Chain
    8.2 Companion Diagnostics (CDx) Development Services Upstream Analysis
    8.3 Companion Diagnostics (CDx) Development Services Midstream Analysis
    8.4 Companion Diagnostics (CDx) Development Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Companion Diagnostics (CDx) Development Services Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Companion Diagnostics (CDx) Development Services Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Companion Diagnostics (CDx) Development Services Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Companion Diagnostics (CDx) Development Services Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Companion Diagnostics (CDx) Development Services Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Companion Diagnostics (CDx) Development Services Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Companion Diagnostics (CDx) Development Services Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Companion Diagnostics (CDx) Development Services Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Companion Diagnostics (CDx) Development Services Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Companion Diagnostics (CDx) Development Services Players in 2022
    Table 12. World Companion Diagnostics (CDx) Development Services Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Companion Diagnostics (CDx) Development Services Company Evaluation Quadrant
    Table 14. Head Office of Key Companion Diagnostics (CDx) Development Services Player
    Table 15. Companion Diagnostics (CDx) Development Services Market: Company Product Type Footprint
    Table 16. Companion Diagnostics (CDx) Development Services Market: Company Product Application Footprint
    Table 17. Companion Diagnostics (CDx) Development Services Mergers & Acquisitions Activity
    Table 18. United States VS China Companion Diagnostics (CDx) Development Services Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Companion Diagnostics (CDx) Development Services Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Companion Diagnostics (CDx) Development Services Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Companion Diagnostics (CDx) Development Services Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Companion Diagnostics (CDx) Development Services Revenue Market Share (2018-2023)
    Table 23. China Based Companion Diagnostics (CDx) Development Services Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Companion Diagnostics (CDx) Development Services Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Companion Diagnostics (CDx) Development Services Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Companion Diagnostics (CDx) Development Services Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Companion Diagnostics (CDx) Development Services Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Companion Diagnostics (CDx) Development Services Revenue Market Share (2018-2023)
    Table 29. World Companion Diagnostics (CDx) Development Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Companion Diagnostics (CDx) Development Services Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Companion Diagnostics (CDx) Development Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Companion Diagnostics (CDx) Development Services Market Size by Application (2024-2029) & (USD Million)
    Table 35. Geneuity-Clinical Research Services Basic Information, Area Served and Competitors
    Table 36. Geneuity-Clinical Research Services Major Business
    Table 37. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product and Services
    Table 38. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Geneuity-Clinical Research Services Recent Developments/Updates
    Table 40. Geneuity-Clinical Research Services Competitive Strengths & Weaknesses
    Table 41. Interpace Biosciences Basic Information, Area Served and Competitors
    Table 42. Interpace Biosciences Major Business
    Table 43. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product and Services
    Table 44. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Interpace Biosciences Recent Developments/Updates
    Table 46. Interpace Biosciences Competitive Strengths & Weaknesses
    Table 47. Labcorp Basic Information, Area Served and Competitors
    Table 48. Labcorp Major Business
    Table 49. Labcorp Companion Diagnostics (CDx) Development Services Product and Services
    Table 50. Labcorp Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Labcorp Recent Developments/Updates
    Table 52. Labcorp Competitive Strengths & Weaknesses
    Table 53. Quest Diagnostics Basic Information, Area Served and Competitors
    Table 54. Quest Diagnostics Major Business
    Table 55. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product and Services
    Table 56. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Quest Diagnostics Recent Developments/Updates
    Table 58. Quest Diagnostics Competitive Strengths & Weaknesses
    Table 59. Q² Solutions Basic Information, Area Served and Competitors
    Table 60. Q² Solutions Major Business
    Table 61. Q² Solutions Companion Diagnostics (CDx) Development Services Product and Services
    Table 62. Q² Solutions Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Q² Solutions Recent Developments/Updates
    Table 64. Q² Solutions Competitive Strengths & Weaknesses
    Table 65. ResearchDx Basic Information, Area Served and Competitors
    Table 66. ResearchDx Major Business
    Table 67. ResearchDx Companion Diagnostics (CDx) Development Services Product and Services
    Table 68. ResearchDx Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. ResearchDx Recent Developments/Updates
    Table 70. ResearchDx Competitive Strengths & Weaknesses
    Table 71. Almac Diagnostic Services Basic Information, Area Served and Competitors
    Table 72. Almac Diagnostic Services Major Business
    Table 73. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product and Services
    Table 74. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Almac Diagnostic Services Recent Developments/Updates
    Table 76. Almac Diagnostic Services Competitive Strengths & Weaknesses
    Table 77. Biocartis Basic Information, Area Served and Competitors
    Table 78. Biocartis Major Business
    Table 79. Biocartis Companion Diagnostics (CDx) Development Services Product and Services
    Table 80. Biocartis Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Biocartis Recent Developments/Updates
    Table 82. Biocartis Competitive Strengths & Weaknesses
    Table 83. Cerba Research Basic Information, Area Served and Competitors
    Table 84. Cerba Research Major Business
    Table 85. Cerba Research Companion Diagnostics (CDx) Development Services Product and Services
    Table 86. Cerba Research Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Cerba Research Recent Developments/Updates
    Table 88. Cerba Research Competitive Strengths & Weaknesses
    Table 89. Eurofins Scientific Basic Information, Area Served and Competitors
    Table 90. Eurofins Scientific Major Business
    Table 91. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product and Services
    Table 92. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Eurofins Scientific Recent Developments/Updates
    Table 94. Eurofins Scientific Competitive Strengths & Weaknesses
    Table 95. MLM Medical Labs Basic Information, Area Served and Competitors
    Table 96. MLM Medical Labs Major Business
    Table 97. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product and Services
    Table 98. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. MLM Medical Labs Recent Developments/Updates
    Table 100. MLM Medical Labs Competitive Strengths & Weaknesses
    Table 101. Qiagen Basic Information, Area Served and Competitors
    Table 102. Qiagen Major Business
    Table 103. Qiagen Companion Diagnostics (CDx) Development Services Product and Services
    Table 104. Qiagen Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Qiagen Recent Developments/Updates
    Table 106. Qiagen Competitive Strengths & Weaknesses
    Table 107. BGI Genomics Basic Information, Area Served and Competitors
    Table 108. BGI Genomics Major Business
    Table 109. BGI Genomics Companion Diagnostics (CDx) Development Services Product and Services
    Table 110. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. BGI Genomics Recent Developments/Updates
    Table 112. BGI Genomics Competitive Strengths & Weaknesses
    Table 113. MEDx Translational Medicine Basic Information, Area Served and Competitors
    Table 114. MEDx Translational Medicine Major Business
    Table 115. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product and Services
    Table 116. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. MEDx Translational Medicine Recent Developments/Updates
    Table 118. MEDx Translational Medicine Competitive Strengths & Weaknesses
    Table 119. Medical Biological Laboratories (MBL) Basic Information, Area Served and Competitors
    Table 120. Medical Biological Laboratories (MBL) Major Business
    Table 121. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product and Services
    Table 122. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Medical Biological Laboratories (MBL) Recent Developments/Updates
    Table 124. Novogene Basic Information, Area Served and Competitors
    Table 125. Novogene Major Business
    Table 126. Novogene Companion Diagnostics (CDx) Development Services Product and Services
    Table 127. Novogene Companion Diagnostics (CDx) Development Services Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 128. Global Key Players of Companion Diagnostics (CDx) Development Services Upstream (Raw Materials)
    Table 129. Companion Diagnostics (CDx) Development Services Typical Customers
List of Figure
    Figure 1. Companion Diagnostics (CDx) Development Services Picture
    Figure 2. World Companion Diagnostics (CDx) Development Services Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Companion Diagnostics (CDx) Development Services Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Companion Diagnostics (CDx) Development Services Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Companion Diagnostics (CDx) Development Services Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Companion Diagnostics (CDx) Development Services Revenue (2018-2029) & (USD Million)
    Figure 13. Companion Diagnostics (CDx) Development Services Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Companion Diagnostics (CDx) Development Services Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Companion Diagnostics (CDx) Development Services Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Companion Diagnostics (CDx) Development Services by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Companion Diagnostics (CDx) Development Services Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Companion Diagnostics (CDx) Development Services Markets in 2022
    Figure 27. United States VS China: Companion Diagnostics (CDx) Development Services Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Companion Diagnostics (CDx) Development Services Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Companion Diagnostics (CDx) Development Services Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Companion Diagnostics (CDx) Development Services Market Size Market Share by Type in 2022
    Figure 31. Feasibility Studies
    Figure 32. Assay Development
    Figure 33. Analytical Validation
    Figure 34. Clinical Validation
    Figure 35. Others
    Figure 36. World Companion Diagnostics (CDx) Development Services Market Size Market Share by Type (2018-2029)
    Figure 37. World Companion Diagnostics (CDx) Development Services Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Companion Diagnostics (CDx) Development Services Market Size Market Share by Application in 2022
    Figure 39. Infectious Diseases
    Figure 40. Neurological Disorders
    Figure 41. Companion Diagnostics (CDx) Development Services Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Companion Diagnostics (CDx) Development Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Companion Diagnostics (CDx) Development Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Companion Diagnostics (CDx) Development Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Companion Diagnostics (CDx) Development Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Companion Diagnostics (CDx) Development Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Companion Diagnostics (CDx) Development Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

companion diagnostics cdx development services

Companion Diagnostics (CDx) Development Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>